Clinical Research Directory

Inclusion Criteria: Phase I: Quantitative * Diagnosed with stages III or IV solid tumor cancer \*(as per self report for ICCAN patients) * Age 18 or older * As per self report, Latino/a or Hispanic ethnicity * As per self report, fluent in oral Spanish (monolingual) or fluent in oral Spanish and English (bilingual) Phase 2: Qualitative * Enrolled in the quantitative phase of study (as seen above) * Completes the quantitative phase questionnaire * Scores above or below the threshold for the Distress Thermometer (DT≥4 or ≤3) * In the judgment of the investigator, willing and able to be interviewed in Spanish only * Agrees to be audio- recorded Phase 3: Provider Feedback * Professionals working in the mental health field; * Have a caseload of five or more Latino cancer patients per month * Able to communicate and read in Spanish * Agrees to be audio or video-recorded Phase 4: Patient Feedback * Diagnosed with stages III or IV solid tumor cancer \*(as per self report for ICCAN patients) * Age 18 or older * As per self report, Latino/a or Hispanic ethnicity * In the judgment of the investigator, willing and able to be interviewed in Spanish only * Agrees to be audio-recorded Phase 5: Pilot RCT * Diagnosed with stages III or IV solid tumor cancer * Age 18 or older * Latino/a or Hispanic ethnicity * Fluent in oral Spanish (monolingual or bilingual) * Scores above the threshold for the Distress Thermometer (DT≥4) * Agrees to be audio-recorded Exclusion Criteria: Phase 1: Quantitative * In the judgment of the treating physician and/or the consenting professional, presence of significant cognitive impairment (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection * In the judgment of the consenting professional, significant or major disabling medical or psychiatric condition sufficient to preclude meaningful informed consent, interview, or completion of assessment measures (patients whose psychiatric disorder is well controlled by treatment will be eligible) Phase 2: Qualitative * In the judgment of the treating physician and/or the consenting professional, presence of significant cognitive impairment (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection * In the judgment of the consenting professional, significant or major disabling medical or psychiatric condition sufficient to preclude meaningful informed consent, interview, or completion of assessment measures (patients whose psychiatric disorder is well controlled by treatment will be eligible) Phase 4: Patient Feedback * Diagnosed with a major disabling medical or psychiatric condition * Unable to understand the consent procedure * Too ill to participate, all as reported by the patient and/or determined by the investigator's judgment. Phase 5: Pilot RCT * Diagnosed with a major disabling medical * Diagnosed with a major disabling psychiatric condition * Unable to understand the consent procedure * Too ill to participate, all as reported by the patient and/or determined by the investigator's judgment